The successful development of innovative pharmaceutical technologies requires a seamless integration of manufacturing design with regulatory and clinical strategy. This presentation explores the critical components involved in designing a development and manufacturing plan for new drug products and delivery systems, including aspects on Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and the Target Product Profile (TPP). It will highlight how early alignment of these elements ensures quality, safety, and scalability—while directly influencing the efficiency and structure of clinical trials and commercial manufacturing. The focus will be on oral solid drug products.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
I had a great experience and met high profile professionals.
Antonio Menegatti
Politecnico di Milano, Italy
There was ample opportunity to learn from colleagues through the workshop sessions or more formally through speakers either sharing their years of experience or their state of the art research. Well worth attending.
John Gleeson
University of Limerick, Ireland
Was great to meet counterparts in my profession who may share my experiences, but who may also have other ideas and approaches.
Tim Moser
Netherlands Cancer Institute, Netherlands
ASTP brought the right structure and terminology to my knowledge of technology licensing.
René Widmer
ETH Transfer, Switzerland
I learned more in the training course for 3 days than I did in the last 3 months at my job. The lectures were informative & interesting.
Hanna Sonnig
Setterwalls Advokatbyrå, Sweden
Join our newsletter and get the latest news